{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:55:25Z","timestamp":1761562525720,"version":"3.44.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ucl.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T08:05:19Z","timestamp":1562054719000},"page":"315-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Role of Imaging in the Diagnosis, Staging, Response to Treatment, and Surveillance of Patients with Germ Cell Tumors of the Testis"],"prefix":"10.1016","volume":"46","author":[{"given":"Lewis J.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ucl.2019.05.001_bib1","first-page":"135","article-title":"Cancer of the testicle diagnosed by ultrasound and the ultrasonic appearance of the contralateral testicle","volume":"137","author":"Lenz","year":"1991","journal-title":"Scand J Urol Nephrol Suppl"},{"author":"Algaba","key":"10.1016\/j.ucl.2019.05.001_bib2"},{"issue":"3","key":"10.1016\/j.ucl.2019.05.001_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/path.1372","article-title":"Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer","volume":"200","author":"Hoei-Hansen","year":"2003","journal-title":"J\u00a0Pathol"},{"issue":"1","key":"10.1016\/j.ucl.2019.05.001_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/0970-1591.60454","article-title":"Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options","volume":"26","author":"Risk","year":"2010","journal-title":"Indian J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2019.05.001_bib6","first-page":"256","article-title":"Carcinoma-in-situ of the testis\u2014is ultrasound of the testes useful as a screening method?","volume":"16","author":"Lenz","year":"2008","journal-title":"J\u00a0Med Ultrasound"},{"issue":"5","key":"10.1016\/j.ucl.2019.05.001_bib7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1148\/rg.275065172","article-title":"US\u2013MR imaging correlation in pathologic conditions of the scrotum","volume":"27","author":"Kim","year":"2007","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.ucl.2019.05.001_bib8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1148\/rg.303095049","article-title":"MR imaging of scrotal tumors and pseudotumors","volume":"30","author":"Cassidy","year":"2010","journal-title":"Radiographics"},{"key":"10.1016\/j.ucl.2019.05.001_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-014-3437-x","article-title":"Testicular microlithiasis imaging and follow-up: guidelines of the ESUR scrotal imaging subcommittee","author":"Richenberg","year":"2015","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.ucl.2019.05.001_bib10","doi-asserted-by":"crossref","first-page":"W331","DOI":"10.2214\/AJR.07.2267","article-title":"MRI in the histologic characterization of testicular neoplasms","volume":"189","author":"Tsili","year":"2007","journal-title":"Am J Roentgenol"},{"author":"Cramer","key":"10.1016\/j.ucl.2019.05.001_bib11"},{"issue":"6","key":"10.1016\/j.ucl.2019.05.001_bib12","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0090-4295(98)00097-1","article-title":"Inconclusive clinical and ultrasound evaluation of the scrotum: impact of magnetic resonance imaging on patient management and cost","volume":"51","author":"Serra","year":"1998","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2019.05.001_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0090-4295(01)01579-5","article-title":"Magnetic Resonance Imaging of Scrotal Disease: When it Makes the Difference","volume":"59","author":"Muglia","year":"2002","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ucl.2019.05.001_bib14","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1995.13.5.1177","article-title":"Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups","volume":"13","author":"Steyerberg","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2019.05.001_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/andr.288","article-title":"Recent trends in the incidence of testicular germ cell tumors in the United States","volume":"3","author":"Ghazarian","year":"2015","journal-title":"Andrology"},{"issue":"1","key":"10.1016\/j.ucl.2019.05.001_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0720-048X(91)90052-W","article-title":"The role of magnetic resonance imaging and computed tomography in the treatment evaluation of retroperitoneal lymph-node metastases of non-seminomatous testicular tumors","volume":"13","author":"Hogeboom","year":"1991","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.ucl.2019.05.001_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.crad.2008.10.011","article-title":"Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours","volume":"64","author":"Sohaib","year":"2009","journal-title":"Clin Radiol"},{"issue":"10","key":"10.1016\/j.ucl.2019.05.001_bib18","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3109\/0284186X.2015.1043027","article-title":"Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer","volume":"54","author":"Mosavi","year":"2015","journal-title":"Acta Oncol (Madr)"},{"issue":"7","key":"10.1016\/j.ucl.2019.05.001_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/annonc\/mdw164","article-title":"Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)","volume":"27","author":"Tandstad","year":"2016","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2019.05.001_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/028418518302400407","article-title":"Size of normal retroperitoneal lymph nodes","volume":"24","author":"Magnusson","year":"1983","journal-title":"Acta Radiol Diagn (Stockh)"},{"issue":"3","key":"10.1016\/j.ucl.2019.05.001_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/crad.2001.0893","article-title":"MR evaluation of normal retroperitoneal and pelvic lymph nodes","volume":"57","author":"Grubnic","year":"2002","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.ucl.2019.05.001_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2214\/ajr.169.2.9242768","article-title":"CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria","volume":"169","author":"Hilton","year":"1997","journal-title":"Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.ucl.2019.05.001_bib23","first-page":"1759","article-title":"Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes","volume":"154","author":"Leibovitch","year":"1995","journal-title":"J\u00a0Urol"},{"issue":"21","key":"10.1016\/j.ucl.2019.05.001_bib24","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.2006.09.3831","article-title":"18Fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC trial TE22\u2014the NCRI Testis Tumour Clinical Study Group","volume":"25","author":"Huddart","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2019.05.001_bib25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00259-013-2624-3","article-title":"18F-FDG PET\/CT impact on testicular tumours clinical management","volume":"41","author":"Ambrosini","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.ucl.2019.05.001_bib26","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/sj.bjc.6603657","article-title":"CT of the chest can hinder the management of seminoma of the testis; it detects irrelevant abnormalities","volume":"96","author":"Horan","year":"2007","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.ucl.2019.05.001_bib27","first-page":"874","article-title":"Chest staging in testis cancer patients: imaging modality selection based upon risk assessment as determined by abdominal computerized tomography scan results","volume":"150","author":"See","year":"1993","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2019.05.001_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0009-9260(99)91152-2","article-title":"Imaging of the thorax in the management of germ cell testicular tumours","volume":"54","author":"White","year":"1999","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.ucl.2019.05.001_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1200\/JCO.2015.62.7000","article-title":"Brain metastases in patients with germ cell tumors: prognostic factors and treatment options\u2013an analysis from the global germ cell cancer group","volume":"34","author":"Feldman","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.ucl.2019.05.001_bib30","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1200\/jco.2008.26.15_suppl.5020","article-title":"Relapse patterns in 2,466 stage 1 seminoma patients (pts) entered into Medical Research Council randomised trials","volume":"26","author":"Mead","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ucl.2019.05.001_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7978958","article-title":"Retroperitoneal lymph node dissection as primary treatment for metastatic seminoma","volume":"2018","author":"Hu","year":"2018","journal-title":"Adv Urol"},{"issue":"3","key":"10.1016\/j.ucl.2019.05.001_bib32","first-page":"860","article-title":"Surgery for a post-chemotherapy residual mass in seminoma","volume":"157","author":"Herr","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"17","key":"10.1016\/j.ucl.2019.05.001_bib33","first-page":"3740","article-title":"Predictive impact of 2 - 18 Fluoro - 2 - Deoxy - D - Glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma","volume":"19","author":"De Santis","year":"2018"},{"issue":"2","key":"10.1016\/j.ucl.2019.05.001_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejrad.2004.07.012","article-title":"FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals","volume":"54","author":"Becherer","year":"2005","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.ucl.2019.05.001_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000337056","article-title":"Can we rely on PET in the follow-up of advanced seminoma patients?","volume":"88","author":"Siekiera","year":"2012","journal-title":"Urol Int"},{"issue":"3","key":"10.1016\/j.ucl.2019.05.001_bib36","first-page":"936","article-title":"The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma","volume":"179","author":"Hinz","year":"2008","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ucl.2019.05.001_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clgc.2014.02.006","article-title":"Positive FDG-PET\/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature","volume":"12","author":"Bilen","year":"2014","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.ucl.2019.05.001_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/annonc\/mdr052","article-title":"2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial","volume":"23","author":"Bachner","year":"2012","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2019.05.001_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<337::AID-CNCR18>3.0.CO;2-U","article-title":"Sarcoidosis and testicular carcinoma","volume":"83","author":"Rayson","year":"1998","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.ucl.2019.05.001_bib40","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1200\/JCO.2007.12.0899","volume":"26","author":"Albers","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2019.05.001_bib41","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.urology.2013.04.082","article-title":"Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy","volume":"82","author":"Al-Ahmadie","year":"2013","journal-title":"Urology"},{"issue":"23","key":"10.1016\/j.ucl.2019.05.001_bib42","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJM198712033172303","article-title":"Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer","volume":"317","author":"Williams","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ucl.2019.05.001_bib43","first-page":"513","article-title":"Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors","volume":"193","author":"Kundu","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.ucl.2019.05.001_bib44","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/cncr.22898","article-title":"Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor\u202f?","volume":"110","author":"Beck","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ucl.2019.05.001_bib45","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1331::AID-CNCR16>3.0.CO;2-I","article-title":"Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis","volume":"85","author":"Steyerberg","year":"1999","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ucl.2019.05.001_bib46","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2009.23.0755","article-title":"Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery","volume":"28","author":"Kollmannsberger","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"36","key":"10.1016\/j.ucl.2019.05.001_bib47","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1200\/JCO.2008.17.1157","article-title":"[18 F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the german multicenter positron emission tomography study group","volume":"26","author":"Oechsle","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.ucl.2019.05.001_bib48","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/annonc\/mdf282","article-title":"Routine chest X-rays have no additional value in the detection of relapse during routine follow-up of patients treated with chemotherapy for disseminated non-seminomatous testicular cancer","volume":"13","author":"Gietema","year":"2002","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2019.05.001_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1200\/JCO.2014.56.2116","article-title":"Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance","volume":"33","author":"Kollmannsberger","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.ucl.2019.05.001_bib50","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.34.6379","article-title":"Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer","volume":"29","author":"van Walraven","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.ucl.2019.05.001_bib51","volume":"25","author":"Rustin","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ucl.2019.05.001_bib52","article-title":"Detection of relapse by low-dose computed tomography during surveillance in stage I testicular germ cell tumours","author":"Chung","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ucl.2019.05.001_bib54","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejca.2017.07.005","article-title":"ScienceDirect no longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer","volume":"84","author":"La Pena","year":"2017","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.ucl.2019.05.001_bib55","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.ejrad.2016.06.002","article-title":"CT restaging of testicular germ cell tumors: the incidence of isolated pelvic metastases","volume":"85","author":"Sadow","year":"2016","journal-title":"Eur J Radiol"},{"issue":"5","key":"10.1016\/j.ucl.2019.05.001_bib56","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.urology.2005.05.049","article-title":"A\u00a0pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation","volume":"66","author":"Harisinghani","year":"2005","journal-title":"Urology"},{"issue":"12","key":"10.1016\/j.ucl.2019.05.001_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11934-018-0863-3","article-title":"Molecular imaging for evaluation of viable testicular cancer nodal metastases","volume":"19","author":"Joice","year":"2018","journal-title":"Curr Urol Rep"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014319300308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014319300308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:35:59Z","timestamp":1758807359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014319300308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0094014319300308"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2019.05.001","relation":{},"ISSN":["0094-0143"],"issn-type":[{"type":"print","value":"0094-0143"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Imaging in the Diagnosis, Staging, Response to Treatment, and Surveillance of Patients with Germ Cell Tumors of the Testis","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}